Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

ALPPS in neuroendocrine liver metastases not amenable for conventional resection - lessons learned from an interim analysis of the International ALPPS Registry.

Linecker M, Kambakamba P, Raptis DA, Malagó M, Ratti F, Aldrighetti L, Robles-Campos R, Lehwald-Tywuschik N, Knoefel WT, Balci D, Ardiles V, De Santibañes E, Truant S, Pruvot FR, Stavrou GA, Oldhafer KJ, Voskanyan S, Mahadevappa B, Kozyrin I, Low JK, Ferrri V, Vicente E, Prachalias A, Pizanias M, Clift AK, Petrowsky H, Clavien PA, Frilling A.

HPB (Oxford). 2019 Sep 17. pii: S1365-182X(19)30701-4. doi: 10.1016/j.hpb.2019.08.011. [Epub ahead of print]

PMID:
31540885
2.

Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection.

Malczewska A, Frampton AE, Mato Prado M, Ameri S, Dabrowska AF, Zagorac S, Clift AK, Kos-Kudła B, Faiz O, Stebbing J, Castellano L, Frilling A.

Ann Surg. 2019 Aug 1. doi: 10.1097/SLA.0000000000003502. [Epub ahead of print]

3.

Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis.

Frilling A, Clift AK, Braat AJAT, Alsafi A, Wasan HS, Al-Nahhas A, Thomas R, Drymousis P, Habib N, Tait PN.

HPB (Oxford). 2019 Jul;21(7):773-783. doi: 10.1016/j.hpb.2018.12.014. Epub 2019 Feb 5. Review.

PMID:
30733049
4.

Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial).

Ramage JK, Punia P, Faluyi O, Frilling A, Meyer T, Saharan R, Valle JW.

Neuroendocrinology. 2019;108(4):317-327. doi: 10.1159/000497330. Epub 2019 Jan 30.

5.

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity.

Braat AJAT, Kappadath SC, Ahmadzadehfar H, Stothers CL, Frilling A, Deroose CM, Flamen P, Brown DB, Sze DY, Mahvash A, Lam MGEH.

Cardiovasc Intervent Radiol. 2019 Mar;42(3):413-425. doi: 10.1007/s00270-018-2148-0. Epub 2019 Jan 2.

PMID:
30603975
6.

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study.

Carlsen EA, Fazio N, Granberg D, Grozinsky-Glasberg S, Ahmadzadehfar H, Grana CM, Zandee WT, Cwikla J, Walter MA, Oturai PS, Rinke A, Weaver A, Frilling A, Gritti S, Arveschoug AK, Meirovitz A, Knigge U, Sorbye H.

Endocr Relat Cancer. 2019 Feb 1;26(2):227-239. doi: 10.1530/ERC-18-0424.

PMID:
30540557
7.

Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.

Baudin E, Hayes AR, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudła B, Gorbunova V, Wiedenmann B, Nieveen van Dijkum E, Ćwikła JB, Falkerby J, Valle JW, Kulke MH, Caplin ME; ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):7-17. doi: 10.1159/000493980. Epub 2018 Sep 24.

PMID:
30248673
8.

Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).

Sorbye H, Baudin E, Borbath I, Caplin M, Chen J, Cwikla JB, Frilling A, Grossman A, Kaltsas G, Scarpa A, Welin S, Garcia-Carbonero R; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):54-62. doi: 10.1159/000493318. Epub 2018 Aug 28.

9.

Surgical Approaches to the Management of Neuroendocrine Liver Metastases.

Frilling A, Clift AK.

Endocrinol Metab Clin North Am. 2018 Sep;47(3):627-643. doi: 10.1016/j.ecl.2018.04.001. Epub 2018 Jul 11. Review.

PMID:
30098720
10.

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.

Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova EV, Hagan EA, Bodei L, Clemons PA, Dela Cruz FS, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel Ü, Li Z, Lee J, Li H, LiVolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A.

Nat Genet. 2018 Jul;50(7):979-989. doi: 10.1038/s41588-018-0138-4. Epub 2018 Jun 18.

11.

Liver transplantation and multivisceral transplantation in the management of patients with advanced neuroendocrine tumours.

Clift AK, Frilling A.

World J Gastroenterol. 2018 May 28;24(20):2152-2162. doi: 10.3748/wjg.v24.i20.2152. Review.

12.

Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J.

Oncotarget. 2018 Mar 13;9(19):15164. doi: 10.18632/oncotarget.24689. eCollection 2018 Mar 13.

13.

Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J.

Oncotarget. 2017 Dec 27;9(5):6007-6014. doi: 10.18632/oncotarget.23675. eCollection 2018 Jan 19. Erratum in: Oncotarget. 2018 Mar 13;9(19):15164.

14.

MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.

Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, Christ E, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, Chanson P, de Herder WW, Konukiewitz B, Klöppel G, Stein R, Korbonits M, Ellard S.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1027-1032. doi: 10.1073/pnas.1712262115. Epub 2018 Jan 16.

15.

Goblet cell carcinomas of the appendix: rare but aggressive neoplasms with challenging management.

Clift AK, Kornasiewicz O, Drymousis P, Faiz O, Wasan HS, Kinross JM, Cecil T, Frilling A.

Endocr Connect. 2018 Feb;7(2):268-277. doi: 10.1530/EC-17-0311. Epub 2018 Jan 15.

16.

Neuroendocrine Tumors of the Gastrointestinal Tract.

Frilling A, Herrmann K, Kämmerer D, Toumpanakis C.

Visc Med. 2017 Oct;33(5):368-371. doi: 10.1159/000475539. Epub 2017 Sep 5. No abstract available.

17.

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours.

Mills L, Drymousis P, Vashist Y, Burdelski C, Prachalias A, Srinivasan P, Menon K, Cotoi C, Khan S, Cave J, Armstrong T, Weickert MO, Izbicki J, Schrader J, Frilling A, Ramage JK, Srirajaskanthan R.

Endocr Connect. 2017 Nov;6(8):876-885. doi: 10.1530/EC-17-0293.

18.

Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors.

Frilling A, Clift AK.

Ann Surg Oncol. 2017 Nov;24(12):3466-3468. doi: 10.1245/s10434-017-6055-4. Epub 2017 Aug 16. No abstract available.

19.

Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases.

Ronot M, Clift AK, Baum RP, Singh A, Kulkarni HR, Frilling A, Vilgrain V.

Neuroendocrinology. 2018;106(1):74-88. doi: 10.1159/000479293. Epub 2017 Jul 21. Review.

20.

Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More.

Pawa N, Clift AK, Osmani H, Drymousis P, Cichocki A, Flora R, Goldin R, Patsouras D, Baird A, Malczewska A, Kinross J, Faiz O, Antoniou A, Wasan H, Kaltsas GA, Darzi A, Cwikla JB, Frilling A.

Neuroendocrinology. 2018;106(3):242-251. doi: 10.1159/000478742. Epub 2017 Jun 23.

21.

Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.

Clift AK, Faiz O, Goldin R, Martin J, Wasan H, Liedke MO, Schloericke E, Malczewska A, Rindi G, Kidd M, Modlin IM, Frilling A.

Endocr Connect. 2017 Feb;6(2):71-81. doi: 10.1530/EC-16-0114. Epub 2017 Jan 19.

22.

Neuroendocrine, goblet cell and mixed adeno-neuroendocrine tumours of the appendix: updates, clinical applications and the future.

Clift AK, Frilling A.

Expert Rev Gastroenterol Hepatol. 2017 Mar;11(3):237-247. doi: 10.1080/17474124.2017.1282314. Epub 2017 Jan 20. Review.

PMID:
28081662
23.

Functional imaging in liver tumours.

Ronot M, Clift AK, Vilgrain V, Frilling A.

J Hepatol. 2016 Nov;65(5):1017-1030. doi: 10.1016/j.jhep.2016.06.024. Epub 2016 Jul 6. Review.

24.

Role of Surgeons in the Changing Sociocultural, Political, and Environmental Climate.

Frilling A.

Ann Surg. 2016 Nov;264(5):691-695. No abstract available.

25.

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.

Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM.

Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31.

26.

MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.

Miller HC, Frampton AE, Malczewska A, Ottaviani S, Stronach EA, Flora R, Kaemmerer D, Schwach G, Pfragner R, Faiz O, Kos-Kudła B, Hanna GB, Stebbing J, Castellano L, Frilling A.

Endocr Relat Cancer. 2016 Sep;23(9):711-26. doi: 10.1530/ERC-16-0044. Epub 2016 Jun 27.

27.

Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors.

Dubash SR, Keat N, Mapelli P, Twyman F, Carroll L, Kozlowski K, Al-Nahhas A, Saleem A, Huiban M, Janisch R, Frilling A, Sharma R, Aboagye EO.

J Nucl Med. 2016 Aug;57(8):1207-13. doi: 10.2967/jnumed.115.169532. Epub 2016 May 12.

28.

Treatment of Non-Colorectal Liver Metastases.

Frilling A, Ebert M.

Viszeralmedizin. 2015 Dec;31(6):386. doi: 10.1159/000442900. Epub 2015 Dec 9. No abstract available.

29.

Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies.

Modlin IM, Frilling A, Salem RR, Alaimo D, Drymousis P, Wasan HS, Callahan S, Faiz O, Weng L, Teixeira N, Bodei L, Drozdov I, Kidd M.

Surgery. 2016 Jan;159(1):336-47. doi: 10.1016/j.surg.2015.06.056. Epub 2015 Oct 9.

PMID:
26456125
30.

Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.

Clift AK, Faiz O, Al-Nahhas A, Bockisch A, Liedke MO, Schloericke E, Wasan H, Martin J, Ziprin P, Moorthy K, Frilling A.

J Gastrointest Surg. 2016 Jan;20(1):180-8; discussion 188. doi: 10.1007/s11605-015-2953-6. Epub 2015 Sep 22.

PMID:
26394880
31.

Consensus on biomarkers for neuroendocrine tumour disease.

Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J.

Lancet Oncol. 2015 Sep;16(9):e435-e446. doi: 10.1016/S1470-2045(15)00186-2. Review.

32.

Transplantation and Debulking Procedures for Neuroendocrine Tumors.

Frilling A, Al-Nahhas A, Clift AK.

Front Horm Res. 2015;44:164-76. doi: 10.1159/000382145. Epub 2015 Aug 14. Review.

PMID:
26303711
33.

MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.

Fischer MA, Raptis DA, Donati OF, Hunziker R, Schade E, Sotiropoulos GC, McCall J, Bartlett A, Bachellier P, Frilling A, Breitenstein S, Clavien PA, Alkadhi H, Patak MA.

Eur J Radiol. 2015 Oct;84(10):1879-87. doi: 10.1016/j.ejrad.2015.06.029. Epub 2015 Jul 2.

PMID:
26194029
34.

Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome.

Miller HC, Kidd M, Modlin IM, Cohen P, Dina R, Drymousis P, Vlavianos P, Klöppel G, Frilling A.

World J Gastrointest Surg. 2015 Apr 27;7(4):60-6. doi: 10.4240/wjgs.v7.i4.60.

35.

Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.

Clift AK, Drymousis P, Al-Nahhas A, Wasan H, Martin J, Holm S, Frilling A.

Neuroendocrinology. 2015;102(1-2):26-32. doi: 10.1159/000381716. Epub 2015 Mar 21. Review.

PMID:
25824138
36.

Management of patients with hepatic metastases from neuroendocrine tumors.

Clift AK, Frilling A.

Ann Saudi Med. 2014 Jul-Aug;34(4):279-90. doi: 10.5144/0256-4947.2014.279. Review.

37.

Modified liver-free multivisceral transplantation for a metastatic small bowel neuroendocrine tumor: a case report.

Frilling A, Giele H, Vrakas G, Reddy S, Macedo R, Al-Nahhas A, Wasan H, Clift AK, Gondolesi GE, Vianna RM, Friend P, Vaidya A.

Transplant Proc. 2015 Apr;47(3):858-62. doi: 10.1016/j.transproceed.2015.01.007. Epub 2015 Feb 15.

PMID:
25689880
38.

Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.

Tran K, Khan S, Taghizadehasl M, Palazzo F, Frilling A, Todd JF, Al-Nahhas A.

Hell J Nucl Med. 2015 Jan-Apr;18(1):19-24. doi: 10.1967/s002449910163. Epub 2015 Feb 13.

39.

Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.

Ramachandran R, Bech P, Murphy KG, Caplin ME, Patel M, Vohra S, Khan MS, Dhillo WS, Sharma R, Palazzo FF, Win Z, Tan T, Khoo B, Meeran K, Frilling A, Ghatei MA, Bloom SR, Martin NM.

J Clin Endocrinol Metab. 2015 Apr;100(4):1520-8. doi: 10.1210/jc.2014-3640. Epub 2015 Feb 9.

40.

Primary lymph node gastrinoma: 2 cases and a review of the literature.

Harper S, Carroll RW, Frilling A, Wickremesekera SK, Bann S.

J Gastrointest Surg. 2015 Apr;19(4):651-5. doi: 10.1007/s11605-014-2729-4. Epub 2015 Jan 27. Review.

PMID:
25623161
41.

Therapeutic strategies for neuroendocrine liver metastases.

Frilling A, Clift AK.

Cancer. 2015 Apr 15;121(8):1172-86. doi: 10.1002/cncr.28760. Epub 2014 Oct 1. Review.

42.

Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours.

Frilling A, Smith G, Clift AK, Martin J.

Dig Liver Dis. 2014 Nov;46(11):1038-42. doi: 10.1016/j.dld.2014.07.004. Epub 2014 Jul 31.

PMID:
25086997
43.

Liver transplantation for neuroendocrine tumour liver metastases.

Fan ST, Le Treut YP, Mazzaferro V, Burroughs AK, Olausson M, Breitenstein S, Frilling A.

HPB (Oxford). 2015 Jan;17(1):23-8. doi: 10.1111/hpb.12308. Epub 2014 Jul 3. Review.

44.

Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.

Miller HC, Drymousis P, Flora R, Goldin R, Spalding D, Frilling A.

World J Surg. 2014 Jun;38(6):1353-61. doi: 10.1007/s00268-014-2451-0.

PMID:
24493070
45.

Recommendations for management of patients with neuroendocrine liver metastases.

Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, Kwekkeboom D, Lau WY, Klersy C, Vilgrain V, Davidson B, Siegler M, Caplin M, Solcia E, Schilsky R; Working Group on Neuroendocrine Liver Metastases.

Lancet Oncol. 2014 Jan;15(1):e8-21. doi: 10.1016/S1470-2045(13)70362-0. Review.

PMID:
24384494
46.

Metabonomic profiling: a novel approach in neuroendocrine neoplasias.

Kinross JM, Drymousis P, Jiménez B, Frilling A.

Surgery. 2013 Dec;154(6):1185-92; discussion 1192-3.

PMID:
24383116
47.

Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis.

Drymousis P, Raptis DA, Spalding D, Fernandez-Cruz L, Menon D, Breitenstein S, Davidson B, Frilling A.

HPB (Oxford). 2014 May;16(5):397-406. doi: 10.1111/hpb.12162. Epub 2013 Nov 7. Review.

48.

German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A; German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V.

Langenbecks Arch Surg. 2013 Mar;398(3):347-75. doi: 10.1007/s00423-013-1057-6. Epub 2013 Mar 3. Review.

PMID:
23456424
49.

Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases (Br J Surg 2012; 99: 1480-1486).

Frilling A.

Br J Surg. 2012 Nov;99(11):1486-7. doi: 10.1002/bjs.8913. No abstract available.

PMID:
23027070
50.

Neuroendocrine tumor disease: an evolving landscape.

Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM.

Endocr Relat Cancer. 2012 Sep 14;19(5):R163-85. doi: 10.1530/ERC-12-0024. Print 2012 Oct. Review.

PMID:
22645227

Supplemental Content

Loading ...
Support Center